CD95 ligand expression as a criterion of malignant transformation in breast cancer. [electronic resource]
- The Journal of pathology Aug 2000
- 468-70 p. digital
Publication Type: Letter; Comment
0022-3417
10.1002/1096-9896(200008)191:4<468::AID-PATH647>3.0.CO;2-J doi
Breast Neoplasms--immunology Cell Transformation, Neoplastic--immunology Cells, Cultured--immunology Female Humans Ligands Lymphocytes, Tumor-Infiltrating--immunology Polymerase Chain Reaction Research Design fas Receptor--immunology